氮卓斯汀联合恩再适治疗慢性荨麻疹的临床观察

The clinical observation of azelastine joint analgecine for treatment of chronic urticaria

目的观察氮卓斯汀联合恩再适治疗慢性荨麻疹的疗效。方法将86例慢性荨麻疹患者随机分为两组，治疗组46例（氮卓斯汀联合恩再适治疗），对照组40例（单用氮卓斯汀治疗），观察两组疗效。结果治疗组总有效率为89．196，对照组总有效率为62．596，两组比较有显著性差异（P〈0．05）。结论氮卓斯汀联合恩再适治疗慢性荨麻疹疗效确切，安全性良好。

Objective To observe the therapeutic effectiveness of Azelastine joint Analgeeine for treatment of chronic urticaria. Methods 86 cases of chronic urticaria patients were divided into two groups randomly, treatment group with 46 patients （Azelastine joint Analgecine）, 40 patients in the collator group （use Azelastine only） to compare with the therapeutic effectiveness of the two groups. Results The cure effective rate was 89. 1% for the treatment group, 62.5% for the collator group, the difference between the two groups are significant（P〈0.05）.Conclusion The therapeutic effectiveness of Azelastine joint Analgecine for treatment of chronic urticaria is definite efficacy, it＇s safe.